TSHA earnings: a positive outcome, +7.1%

On May 14, 2024, Taysha Gene Therapies, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.1% in the window around the event. It had already run -20.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.